RxDoctor Payments Data

Kalli Wilks

Primary Care · Pensacola, FLNPI 1083308464

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 10.4% — the pattern of someone who eats at a lot of different presentations.

$989in general payments, 2019–2025

Across 54 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$103
  • Novartis$102
  • Bristol Myers Squibb$95
  • Johnson & Johnson$64
  • Merck$63
  • AVEO Pharmaceuticals, Inc.$59
  • plus $502 from 17 others

What the payments were for

  • Food & beverage$989100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$989 in reported general payments places this provider in the 70th percentile of 725 primary care providers in Florida.

See all primary care providers in Florida →

Other primary care in Pensacola

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →